Daniel Ek's Neko Health Raises $700M at a $7B Valuation to Scan America
The Spotify founder's preventive-care startup is bringing its AI body-scanning clinics to the U.S. — and investors think prevention is the next platform.
Neko Health, the preventive-care startup co-founded by Spotify's Daniel Ek, has raised $700 million at a $7 billion valuation to fund its expansion into the United States — one of the largest health-tech rounds ever for a company built around a simple idea: scan people before they get sick.
Neko's clinics run full-body scans combining dozens of sensors with AI analysis, delivering a same-day readout of cardiovascular, skin and metabolic markers. In Europe, demand has famously outrun supply, with waiting lists stretching months.
Why investors are paying up
Healthcare spending is overwhelmingly reactive; the economic prize for catching disease early is enormous. Falling sensor costs and dramatically better AI mean a one-hour scan can now surface risks that once required a dozen specialist visits. Neko's bet is that preventive scanning becomes a recurring consumer habit — a health "subscription" — rather than a luxury one-off.
The skeptics' case
Critics warn of over-diagnosis, incidental findings that trigger unnecessary procedures, and the regulatory gauntlet of American medicine. U.S. expansion also means confronting insurers, state licensing and the FDA. But with $700 million in fresh capital and a founder who already rewired one industry, Neko has the resources to find out whether prevention can finally be a business — not just advice.
